I+D de fármacos
GI-1606
Universidad San Sebastián
Concepción, ChilePublicacións en colaboración con investigadores/as de Universidad San Sebastián (1)
2023
-
In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies
Journal of Biomolecular Structure and Dynamics, Vol. 41, Núm. 22, pp. 13250-13259